Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Kao

Concepts (373)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
35
2026
2334
4.920
Why?
Machine Learning
8
2025
596
2.210
Why?
Stroke Volume
17
2025
658
1.860
Why?
Adrenergic beta-Antagonists
10
2025
252
1.520
Why?
Methadone
5
2023
131
1.400
Why?
Pregnancy Complications, Cardiovascular
5
2022
85
1.400
Why?
Buprenorphine
3
2023
201
1.290
Why?
Cardiomyopathies
5
2022
339
1.290
Why?
United States Food and Drug Administration
5
2024
208
1.190
Why?
Decision Support Systems, Clinical
6
2024
278
1.130
Why?
Cardiomyopathy, Dilated
9
2025
358
1.100
Why?
Pharmacogenetics
5
2024
176
1.100
Why?
Adverse Drug Reaction Reporting Systems
4
2024
81
1.070
Why?
Arrhythmias, Cardiac
6
2023
360
1.040
Why?
Cytochrome P-450 CYP2C19
4
2024
29
0.950
Why?
Electronic Health Records
7
2024
1214
0.930
Why?
Propanolamines
3
2019
40
0.880
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
448
0.840
Why?
Hospitalization
10
2024
2496
0.820
Why?
Workflow
2
2026
183
0.820
Why?
Telemedicine
4
2024
978
0.730
Why?
Atrial Fibrillation
5
2026
560
0.720
Why?
Torsades de Pointes
4
2016
23
0.710
Why?
Seasons
1
2024
540
0.700
Why?
Pulmonary Edema
1
2021
105
0.680
Why?
Humans
88
2026
147293
0.670
Why?
Coffee
1
2021
16
0.660
Why?
Pharmacogenomic Testing
4
2022
63
0.640
Why?
Stroke
2
2021
1287
0.620
Why?
Platelet Aggregation Inhibitors
1
2024
499
0.610
Why?
Aged
33
2026
26514
0.590
Why?
Defibrillators, Implantable
2
2021
395
0.590
Why?
Prosthesis Failure
1
2020
127
0.580
Why?
Artificial Intelligence
2
2026
389
0.580
Why?
Prosthesis-Related Infections
1
2020
99
0.570
Why?
Long QT Syndrome
3
2016
68
0.570
Why?
Mobile Applications
1
2021
199
0.570
Why?
Spironolactone
1
2019
40
0.560
Why?
Device Removal
1
2020
149
0.560
Why?
Pacemaker, Artificial
1
2020
128
0.560
Why?
United States
22
2025
16313
0.550
Why?
Risk Assessment
10
2026
3784
0.550
Why?
Medical Records
2
2019
192
0.550
Why?
Coronary Disease
1
2021
382
0.550
Why?
Mineralocorticoid Receptor Antagonists
1
2019
69
0.540
Why?
Diabetes Mellitus
2
2024
1107
0.540
Why?
Periodicals as Topic
1
2020
211
0.530
Why?
Biomedical Research
2
2024
723
0.530
Why?
Mortality
3
2019
382
0.520
Why?
Retrospective Studies
22
2026
17560
0.510
Why?
Hypertension, Pregnancy-Induced
1
2018
69
0.500
Why?
Receptors, Transforming Growth Factor beta
1
2017
55
0.490
Why?
Female
50
2026
80076
0.490
Why?
Hospital Records
1
2016
10
0.490
Why?
Proteoglycans
1
2017
112
0.480
Why?
Ventricular Function, Left
5
2025
546
0.470
Why?
Analgesics, Opioid
2
2023
1167
0.470
Why?
Hospital Mortality
6
2024
1043
0.460
Why?
Disease Management
1
2020
654
0.450
Why?
Survival
1
2015
38
0.450
Why?
Tetrazoles
1
2015
50
0.440
Why?
Biphenyl Compounds
1
2015
67
0.440
Why?
Electrocardiography
5
2026
675
0.440
Why?
Male
42
2026
73950
0.440
Why?
Middle Aged
30
2025
36821
0.430
Why?
Muscle Proteins
2
2025
244
0.430
Why?
Myocardial Infarction
3
2018
1213
0.420
Why?
Research Design
1
2020
1157
0.410
Why?
Ventricular Remodeling
3
2025
283
0.400
Why?
Loperamide
2
2023
12
0.400
Why?
Myocardium
3
2017
947
0.380
Why?
Tachycardia, Ventricular
1
2015
182
0.380
Why?
Diet
1
2021
1284
0.380
Why?
Polymorphism, Single Nucleotide
4
2017
2223
0.380
Why?
Registries
2
2020
2434
0.370
Why?
Precision Medicine
6
2024
464
0.370
Why?
Legislation, Medical
1
2012
11
0.370
Why?
Adult
28
2024
41405
0.360
Why?
Amiodarone
1
2012
31
0.360
Why?
Peripartum Period
4
2022
19
0.360
Why?
Phenotype
5
2025
3216
0.360
Why?
Patient Readmission
1
2018
777
0.350
Why?
Quality Improvement
2
2020
1321
0.340
Why?
Anti-Arrhythmia Agents
1
2012
144
0.340
Why?
Pyrazines
2
2008
94
0.330
Why?
Sex Factors
4
2024
2136
0.330
Why?
Heart Arrest
4
2019
412
0.330
Why?
Catheter Ablation
1
2015
360
0.330
Why?
Transfusion Reaction
1
2011
61
0.320
Why?
Cardiovascular Diseases
5
2024
2218
0.320
Why?
Forecasting
2
2024
391
0.320
Why?
Treatment Outcome
10
2025
11947
0.320
Why?
Heart-Assist Devices
1
2016
571
0.310
Why?
Triazoles
2
2008
191
0.310
Why?
Echocardiography
3
2024
652
0.310
Why?
Risk Factors
10
2025
11017
0.300
Why?
Postoperative Complications
2
2020
3022
0.290
Why?
Insurance, Health
1
2012
321
0.290
Why?
Patient Discharge
2
2021
1002
0.290
Why?
Databases, Factual
5
2020
1504
0.290
Why?
Anemia
1
2011
192
0.290
Why?
Thiazolidinediones
1
2010
143
0.290
Why?
Patient Transfer
1
2012
224
0.290
Why?
Genotype
3
2024
1875
0.280
Why?
Marketing
1
2008
24
0.280
Why?
Renal Insufficiency
1
2011
172
0.280
Why?
Rhabdomyolysis
1
2008
24
0.280
Why?
Drug Industry
1
2008
49
0.280
Why?
Simvastatin
1
2008
59
0.280
Why?
Aged, 80 and over
7
2024
8430
0.270
Why?
Receptors, Adrenergic, beta-1
4
2019
24
0.270
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
46
0.270
Why?
Heart Ventricles
4
2017
767
0.270
Why?
Incidence
6
2025
2954
0.270
Why?
Heart Rate
3
2025
860
0.270
Why?
Follow-Up Studies
7
2025
5476
0.260
Why?
Cytochrome P-450 CYP2D6
3
2022
33
0.260
Why?
Length of Stay
4
2024
1371
0.260
Why?
Kaplan-Meier Estimate
3
2016
975
0.250
Why?
Proportional Hazards Models
4
2021
1344
0.250
Why?
Pharmacovigilance
2
2024
25
0.250
Why?
Practice Patterns, Physicians'
3
2020
1379
0.240
Why?
Elective Surgical Procedures
2
2020
203
0.230
Why?
Biological Specimen Banks
3
2024
137
0.230
Why?
Atrial Flutter
1
2026
47
0.230
Why?
Gene Expression Regulation
1
2015
2625
0.230
Why?
Emergency Service, Hospital
2
2020
2416
0.220
Why?
Patient Reported Outcome Measures
2
2020
506
0.220
Why?
Cause of Death
2
2019
475
0.210
Why?
New York
1
2024
128
0.210
Why?
Glucose
1
2010
1051
0.210
Why?
Diabetic Cardiomyopathies
1
2024
34
0.210
Why?
Pandemics
3
2022
1720
0.200
Why?
Pregnancy
6
2022
7274
0.200
Why?
Young Adult
9
2022
14437
0.200
Why?
Diphenoxylate
1
2023
5
0.200
Why?
Acute Kidney Injury
2
2008
880
0.190
Why?
Adolescent
10
2020
22825
0.190
Why?
Randomized Controlled Trials as Topic
3
2021
1776
0.190
Why?
Monitoring, Physiologic
1
2024
290
0.180
Why?
Nonprescription Drugs
1
2023
69
0.180
Why?
Prognosis
5
2020
4383
0.180
Why?
Heart Defects, Congenital
2
2020
941
0.180
Why?
Naltrexone
1
2023
115
0.180
Why?
Algorithms
4
2025
1868
0.170
Why?
Medicare
2
2020
915
0.170
Why?
Insulin Resistance
1
2010
1253
0.170
Why?
Red Meat
1
2021
7
0.170
Why?
Speech
1
2021
76
0.170
Why?
Hypertension
2
2020
1280
0.160
Why?
Time Factors
3
2020
7173
0.160
Why?
Data Interpretation, Statistical
2
2020
369
0.160
Why?
Losartan
1
2020
13
0.160
Why?
Lisinopril
1
2020
15
0.160
Why?
Drug Dosage Calculations
1
2020
27
0.160
Why?
Protective Factors
1
2021
102
0.160
Why?
Smartphone
1
2021
107
0.160
Why?
Angioedema
1
2020
16
0.160
Why?
Actigraphy
1
2021
148
0.160
Why?
Cardiac Resynchronization Therapy
1
2021
63
0.160
Why?
Wearable Electronic Devices
1
2021
75
0.160
Why?
American Heart Association
2
2019
363
0.160
Why?
Milk
1
2021
119
0.160
Why?
Data Accuracy
1
2020
65
0.160
Why?
Turner Syndrome
1
2021
65
0.150
Why?
Hypoglycemic Agents
1
2010
1415
0.150
Why?
Indans
1
2020
13
0.150
Why?
Editorial Policies
1
2020
45
0.150
Why?
Oxadiazoles
1
2020
37
0.150
Why?
Bionics
1
2019
14
0.150
Why?
Biological Products
1
2023
258
0.150
Why?
California
2
2012
477
0.150
Why?
Medical Informatics
1
2020
100
0.150
Why?
Fingolimod Hydrochloride
1
2020
40
0.150
Why?
Medical Futility
1
2019
32
0.150
Why?
Software
2
2015
683
0.150
Why?
Medical Record Linkage
1
2020
69
0.150
Why?
Referral and Consultation
2
2017
886
0.150
Why?
Prescription Drugs
1
2020
111
0.140
Why?
Information Storage and Retrieval
1
2020
123
0.140
Why?
Drug Overdose
1
2023
381
0.140
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2020
83
0.140
Why?
Sitagliptin Phosphate
2
2008
31
0.140
Why?
Medical Order Entry Systems
1
2019
40
0.140
Why?
Drug Prescriptions
1
2021
293
0.140
Why?
Dose-Response Relationship, Drug
4
2020
2030
0.140
Why?
Child Health Services
1
2020
191
0.140
Why?
Cluster Analysis
1
2019
502
0.140
Why?
Computer Graphics
2
2015
41
0.140
Why?
Tobacco Use
1
2019
68
0.130
Why?
Cohort Studies
3
2021
6099
0.130
Why?
Receptors, Histamine H2
1
2017
6
0.130
Why?
Social Determinants of Health
1
2022
322
0.130
Why?
Gene Regulatory Networks
2
2023
318
0.130
Why?
Florida
1
2018
118
0.130
Why?
Advisory Committees
1
2019
233
0.130
Why?
Neisseria gonorrhoeae
1
1997
29
0.130
Why?
Porins
1
1997
18
0.130
Why?
Consensus
1
2019
476
0.130
Why?
Dyslipidemias
1
2019
185
0.120
Why?
Nursing Assessment
1
2017
54
0.120
Why?
Prospective Studies
4
2021
8164
0.120
Why?
Heart Diseases
1
2020
341
0.120
Why?
Pressure Ulcer
1
2017
41
0.120
Why?
Population Surveillance
1
2020
486
0.120
Why?
Academic Medical Centers
1
2020
566
0.120
Why?
Patient Participation
1
2020
449
0.120
Why?
Antihypertensive Agents
1
2020
522
0.120
Why?
Hospitals, Teaching
1
2017
122
0.120
Why?
Tilidine
1
2016
2
0.120
Why?
Genetic Markers
1
2017
338
0.120
Why?
Cardiology
1
2019
364
0.120
Why?
Double-Blind Method
3
2025
2080
0.110
Why?
Oxycodone
1
2016
52
0.110
Why?
Databases, Genetic
1
2017
240
0.110
Why?
Rheumatic Fever
1
2015
6
0.110
Why?
Rheumatic Heart Disease
1
2015
5
0.110
Why?
Sex Distribution
1
2016
390
0.110
Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
39
0.110
Why?
Cholesterol Ester Transfer Proteins
1
2015
22
0.110
Why?
Hospitals, Low-Volume
1
2015
26
0.110
Why?
Gene Expression Profiling
3
2017
1794
0.110
Why?
Immunosuppressive Agents
1
2020
840
0.110
Why?
Angiotensin II
1
2015
102
0.110
Why?
Oligonucleotide Array Sequence Analysis
1
2017
751
0.110
Why?
Computational Biology
2
2017
677
0.110
Why?
Hospitals, High-Volume
1
2015
50
0.110
Why?
Naloxone
1
2016
138
0.110
Why?
Marijuana Use
1
2018
222
0.100
Why?
Mothers
1
2020
774
0.100
Why?
Percutaneous Coronary Intervention
1
2020
549
0.100
Why?
United Kingdom
1
2015
391
0.100
Why?
Biomarkers
2
2024
4351
0.100
Why?
Age Factors
2
2019
3372
0.100
Why?
International Classification of Diseases
1
2015
151
0.100
Why?
Comorbidity
1
2019
1672
0.100
Why?
Gene Expression
2
2017
1481
0.100
Why?
Chronic Disease
2
2020
1844
0.100
Why?
Down-Regulation
1
2015
618
0.100
Why?
MicroRNAs
2
2017
694
0.100
Why?
Narcotic Antagonists
1
2015
210
0.100
Why?
Cholesterol
1
2015
410
0.100
Why?
Ventricular Dysfunction, Left
2
2020
394
0.090
Why?
Federal Government
1
2012
23
0.090
Why?
Coronary Artery Disease
1
2019
754
0.090
Why?
Drug Resistance
1
2012
145
0.090
Why?
RNA, Messenger
2
2017
2812
0.090
Why?
Myocytes, Cardiac
1
2017
547
0.090
Why?
Area Under Curve
1
2012
334
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
928
0.080
Why?
Genetic Predisposition to Disease
2
2017
2458
0.080
Why?
Colorado
4
2024
4591
0.080
Why?
Predictive Value of Tests
1
2017
2133
0.080
Why?
Patient Safety
1
2015
356
0.080
Why?
Gastrointestinal Hemorrhage
1
2012
139
0.080
Why?
Anti-Retroviral Agents
1
2013
251
0.080
Why?
Bayes Theorem
1
2012
428
0.080
Why?
Managed Care Programs
2
2022
140
0.080
Why?
Opiate Substitution Treatment
1
2013
198
0.080
Why?
Survival Rate
1
2015
2110
0.080
Why?
Endoscopy, Gastrointestinal
1
2012
237
0.080
Why?
Pregnancy Outcome
1
2013
506
0.080
Why?
Delivery of Health Care
1
2017
951
0.080
Why?
Genome-Wide Association Study
1
2017
1496
0.080
Why?
Multivariate Analysis
1
2012
1550
0.070
Why?
Severity of Illness Index
1
2017
2973
0.070
Why?
Pharmacogenomic Variants
2
2019
35
0.070
Why?
Drug Approval
1
2008
93
0.070
Why?
Primary Health Care
1
2019
1759
0.070
Why?
Emergency Medical Services
1
2015
691
0.070
Why?
Vasodilator Agents
1
2010
330
0.070
Why?
Logistic Models
1
2012
2142
0.060
Why?
Kidney Function Tests
1
2007
156
0.060
Why?
Animals
3
2023
38410
0.060
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
267
0.060
Why?
Zimbabwe
2
2017
76
0.060
Why?
Drug Therapy, Combination
1
2008
1046
0.060
Why?
Reproducibility of Results
2
2026
3448
0.060
Why?
Models, Biological
1
2012
1772
0.050
Why?
Case-Control Studies
1
2012
3660
0.050
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
39
0.050
Why?
Opioid-Related Disorders
1
2013
617
0.050
Why?
Canada
1
2026
435
0.050
Why?
Psychological Tests
1
2005
131
0.050
Why?
Osteoporosis, Postmenopausal
1
2004
41
0.050
Why?
Potassium Channels
1
2025
148
0.050
Why?
Mandible
1
2004
73
0.050
Why?
Depression
2
2022
1599
0.050
Why?
Receptors, Adrenergic
1
2023
20
0.050
Why?
Cross-Sectional Studies
3
2022
6011
0.050
Why?
Drug Administration Schedule
2
2020
789
0.050
Why?
Cardiovascular Agents
1
2025
166
0.050
Why?
Carcinoembryonic Antigen
1
2002
40
0.040
Why?
Antigens, Differentiation
1
2002
76
0.040
Why?
Child
5
2020
22979
0.040
Why?
Antigens, Bacterial
1
2002
126
0.040
Why?
Electronic Prescribing
1
2021
4
0.040
Why?
Cell Adhesion Molecules
1
2002
182
0.040
Why?
Vitamin K Epoxide Reductases
1
2020
12
0.040
Why?
Health Services Misuse
1
2020
35
0.040
Why?
Antigens, Neoplasm
1
2002
273
0.040
Why?
Insurance Claim Reporting
1
2020
26
0.040
Why?
Antidepressive Agents
1
2022
245
0.040
Why?
Lymphocyte Count
1
2020
165
0.040
Why?
Morbidity
1
2020
323
0.040
Why?
Metoprolol
1
2019
26
0.040
Why?
Membrane Glycoproteins
1
2002
499
0.040
Why?
Antineoplastic Agents
1
2010
2231
0.040
Why?
Grounded Theory
1
2019
46
0.040
Why?
Bias
1
2020
201
0.040
Why?
Aftercare
1
2020
225
0.040
Why?
Antigens, CD
1
2002
562
0.040
Why?
Genomics
1
2024
839
0.030
Why?
Mice, Transgenic
1
2023
2197
0.030
Why?
Coronary Angiography
1
2020
329
0.030
Why?
Amino Acid Sequence
2
2002
2134
0.030
Why?
HIV Infections
1
2013
3235
0.030
Why?
Delivery of Health Care, Integrated
1
2020
303
0.030
Why?
Static Electricity
1
1997
115
0.030
Why?
Molecular Sequence Data
2
2002
2886
0.030
Why?
Exercise Test
1
2020
636
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2017
104
0.030
Why?
Inpatients
1
2021
556
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2017
337
0.030
Why?
Frail Elderly
1
2017
136
0.030
Why?
Metabolic Networks and Pathways
1
2017
175
0.030
Why?
Socioeconomic Factors
1
2020
1342
0.030
Why?
Focus Groups
1
2019
587
0.030
Why?
World Health Organization
1
2016
105
0.030
Why?
Puerperal Disorders
1
2016
36
0.030
Why?
Physician-Patient Relations
1
2020
594
0.030
Why?
Neoplasms
1
2010
2946
0.030
Why?
Decision Trees
1
2015
78
0.030
Why?
Drug Combinations
1
2016
399
0.030
Why?
Data Mining
1
2015
114
0.030
Why?
Blood Pressure
1
2020
1785
0.020
Why?
Cell Membrane
1
1997
711
0.020
Why?
Biopsy
1
2017
1093
0.020
Why?
Pediatrics
1
2020
1139
0.020
Why?
Models, Genetic
1
2015
536
0.020
Why?
Liver
1
2020
1916
0.020
Why?
Mass Screening
2
2013
1375
0.020
Why?
Infant
2
2015
10194
0.020
Why?
Anthracyclines
1
2010
49
0.020
Why?
Trastuzumab
1
2010
119
0.020
Why?
Angiotensin Receptor Antagonists
1
2010
116
0.020
Why?
Child, Preschool
2
2015
12016
0.020
Why?
Signal Transduction
1
2023
5272
0.020
Why?
Clinical Trials as Topic
1
2015
1072
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
230
0.020
Why?
Program Evaluation
1
2013
952
0.020
Why?
Apoptosis
1
2017
2454
0.020
Why?
Injections, Intravenous
1
2007
198
0.020
Why?
Natriuretic Peptide, Brain
1
2007
111
0.020
Why?
Ultrasonography
1
2010
795
0.020
Why?
Infusions, Intravenous
1
2007
430
0.020
Why?
Mice
1
2023
18491
0.010
Why?
Creatinine
1
2007
516
0.010
Why?
Hospitals, University
1
2005
176
0.010
Why?
Dentists
1
2004
21
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2010
1005
0.010
Why?
Femur Neck
1
2004
62
0.010
Why?
Bone Diseases, Metabolic
1
2004
59
0.010
Why?
Absorptiometry, Photon
1
2004
277
0.010
Why?
Antibodies, Monoclonal
1
2010
1514
0.010
Why?
Nurses
1
2005
171
0.010
Why?
Heparan Sulfate Proteoglycans
1
2002
23
0.010
Why?
Analysis of Variance
1
2004
1302
0.010
Why?
Bone Density
1
2004
493
0.010
Why?
HeLa Cells
1
2002
633
0.010
Why?
Binding Sites
1
2002
1319
0.010
Why?
Clinical Competence
1
2005
1260
0.010
Why?
Physicians
1
2005
961
0.010
Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)